Jay and Pamela both have Osteogenesis Imperfecta Type 3, a condition that causes fragile bones. Both get around in motorized ...

Goldman Sachs reiterated its Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares with a steady price target of $78.00. The firm's analyst highlighted Ultragenyx's fourth-quarter total ...

Jay and Pamela take on their health struggles while also gearing up for their wedding in new docuseries "Jay and Pamela," ...

When Columbus resident Jennifer Roberts’ family gets together for the holidays, they typically play a few games of bingo for ...

Reports Q4 revenue $164.88M, consensus $158.71M. “We have created a next-generation rare disease company on a pathway to profitability with ...

Charlotte Proud, a Sunderland University apprentice born with Osteogenesis Imperfecta (Brittle Bone Disease), is determined ...

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

TLC seems particularly busy lately, announcing some new shows that take the channel in familiar directions and at least one ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website. “Stronger liquidity will ensure our ...

" Jay & Pamela " will be officially premiered on Tuesday, March 4, 2025, at 10/9C. Viewers can tune into the network to see the series and experience the inspirational journey of the couple. For those ...